Cargando…
sFlt-1 Levels as a Predicting Tool in Placental Dysfunction Complications in Multiple Pregnancies
Background: several studies have demonstrated that angiogenic markers can improve the clinical management of hypertensive disorders (HDs) and fetal growth restriction (FGR) in singleton pregnancies, but few studies have evaluated the performance of these tests in multiple pregnancies. Our aim was to...
Autores principales: | Giardini, Valentina, Grilli, Leonora, Terzaghi, Alessandra, Todyrenchuk, Lyudmyla, Zavettieri, Caterina, Mazzoni, Giulia, Cozzolino, Sabrina, Casati, Marco, Vergani, Patrizia, Locatelli, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669317/ https://www.ncbi.nlm.nih.gov/pubmed/38001918 http://dx.doi.org/10.3390/biomedicines11112917 |
Ejemplares similares
-
RNAi Modulation of Placental sFLT1 for the Treatment of Preeclampsia.
por: Turanov, Anton A., et al.
Publicado: (2018) -
sFlt-1/PlGF ratio in hypertensive disorders of pregnancy in patients affected by COVID-19
por: Soldavini, Chiara Maria, et al.
Publicado: (2022) -
Unfractionated heparin displaces sFlt-1 from the placental extracellular matrix
por: Moore, Kyle H., et al.
Publicado: (2020) -
Trophoblast-Targeted Nanomedicine Modulates Placental sFLT1 for Preeclampsia Treatment
por: Li, Lei, et al.
Publicado: (2020) -
Letter to the Editor: SFlt-1 and PlGF Levels in Pregnancies Complicated by SARS-CoV-2 Infection
por: Giardini, Valentina, et al.
Publicado: (2021)